Evidence method
Level · gp.fundamentals.capex_revenue_ratio
2.07% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
CRNX · Jun 30, 2026
Crinetics Pharmaceuticals, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 4[email protected]
Inspectable configuration
State dimensions
Filing0001658247-26-000053General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-375.00% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
2336.28% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
13.89% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.gross_margin
99.39% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-527.35% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
397.52% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
99.06% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History14 statesSelf-history eligible
Sep 30, 20190/6 normalizedLevel 3Dec 31, 20190/6 normalizedLevel 3Mar 31, 20200/6 normalizedLevel 3Dec 31, 20200/6 normalizedLevel 3Mar 31, 20235/6 normalizedLevel 3Jun 30, 20236/6 normalizedLevel 3Sep 30, 20236/6 normalizedLevel 3Mar 31, 20246/6 normalizedLevel 3Jun 30, 20246/6 normalizedLevel 3Mar 31, 20256/6 normalizedLevel 3Jun 30, 20256/6 normalizedLevel 3Dec 31, 20256/8 normalizedLevel 3Mar 31, 20266/8 normalizedLevel 3Jun 30, 20266/8 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 7.64%
- Current
- 2.07%
- Delta
- -5.57%
- Previous
- -1161.76%
- Current
- -375.00%
- Delta
- 786.75%
- Previous
- 2873.41%
- Current
- 2336.28%
- Delta
- -537.13%
- Previous
- 28.54%
- Current
- 13.89%
- Delta
- -14.66%
- Previous
- 98.14%
- Current
- 99.39%
- Delta
- 1.25%
- Previous
- -1307.79%
- Current
- -527.35%
- Delta
- 780.44%
- Previous
- 932.37%
- Current
- 397.52%
- Delta
- -534.85%
- Previous
- 276.50%
- Current
- 99.06%
- Delta
- -177.45%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
- Similarity
- 91%
- Compared
- 6 dimensions
- Coverage
- 100%
- Similarity
- 68%
- Compared
- 5 dimensions
- Coverage
- 83%
- Similarity
- 41%
- Compared
- 6 dimensions
- Coverage
- 100%
- Similarity
- 29%
- Compared
- 6 dimensions
- Coverage
- 100%
- Similarity
- 21%
- Compared
- 6 dimensions
- Coverage
- 100%
Research Graph
Related governed research
Analogous To · CRNX state analogue 2 →Analogous To · CRNX state analogue 3 →Analogous To · CRNX state analogue 1 →Compared To · Pharmaceutical Preparations peers →Analogous To · CRNX state analogue 5 →Analogous To · CRNX state analogue 4 →Has State · Crinetics Pharmaceuticals, Inc. →Transitioned To · CRNX Fundamental State →Transitioned To · CRNX CAPEX_INTENSITY_DECREASED →Transitioned To · CRNX CASH_GENERATION_INCREASED →Transitioned To · CRNX GROWTH_DECREASED →Transitioned To · CRNX INVENTORY_PRESSURE_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.